Pharmaceutical giant Pfizer announced this week that it has started an early stage clinical trial to test an oral antiviral drug for Covid-19. The experimental oral antiviral drug is in a phase one trial called PF-07321332 which is being conducted in the United States. It is the first protease inhibitor taken by mouth for Covid-19 … Continue reading “Pfizer Begins Early Stage Clinical Trial for a Covid-19 Oral Antiviral Drug”
Biotech & Pharma
Biotech & Pharma
Pfizer’s Covid Vaccine Blocks This Much of Asymptomatic Infections
According to an Israeli study, Pfizer has announced that its COVID-19 vaccine blocked 94% of…
March 11, 2021
Biotech & Pharma
J&J’s Single-dose Coronavirus Vaccine Could Change Everything
According to a physician, Johnson & Johnson's single-dose vaccine is a game changer. It is…
March 2, 2021
Biotech & Pharma
Moderna Just Received Positive Feedback from the FDA Over This
Moderna announced this week that it has received "positive feedback" from the Food & Drug…
February 23, 2021
Biotech & Pharma
Walgreens Executive Says Covid Widespread Vaccines Will Soon Be Available
According to Walgreens senior vice president of pharmacy and health care, Rick Gates, COVID-19 vaccines…
February 11, 2021
Biotech & Pharma
J&J COVID-19 Vaccine is This Effective in the United States Compared to Moderna and Pfizer
After a long year of coronavirus in 2020, at least 2021 has a light at…
February 2, 2021
Biotech & Pharma
Moderna Says it is Working on a New Vaccine Against New COVID-19 Variant
Moderna has now become the first vaccine maker to announce a trial for a booster…
January 26, 2021
Biotech & Pharma
Boston Scientific to Acquire Preventice for up to $1.225 Billion
Boston Scientific is planning to purchase privately-held Preventice in a deal that could be worth…
January 21, 2021
Biotech & Pharma
Bluebird Bio Is Spinning Off Its Oncology Business
Gene therapy company Bluebird Bio has revealed this week that the company is spinning off…
January 12, 2021
Biotech & Pharma
Beigene Inks $2.2 Billion Deal with Novartis
Shares of Beigene soared on Tuesday after scoring a cancer drug development deal with Novartis.…
January 12, 2021
Biotech & Pharma
Centene is Buying Magellan Health in a Whopping $2.2 Billion Deal
Centene Corp, a multi-line managed care enterprise that serves as a major intermediary for both…
January 4, 2021
Biotech & Pharma
Amazon-Berkshire-JPMorgan Venture Haven is Already Shutting Down
After only three years, Haven, the venture formed by Amazon, JPMorgan Chase, and Berkshire Hathaway…
January 4, 2021
Biotech & Pharma
Moderna is Increasing its Minimum 2021 Covid Vaccine Production by This Much
Moderna announced on Monday that the company is increasing its minimum 2021 Covid vaccine production…
January 4, 2021
Biotech & Pharma
Analyst Says Bionano’s Genome Mapping Platform Could Be a Game Changer
This month shares of life sciences company Bionano have seen gains of over 300% and…
December 31, 2020